References
  1. Hekimian G, Kharcha F, Bréchot N, Schmidt M, Ghander C, Lebreton G, Girerd X, Tresallet C, Trouillet JL, Leprince P, Chastre J, Combes A, Luyt CE. Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann. Intensive Care2016; 6:117.
  2. Simons M, Downing SE. Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J 1985; 109(2):297–304.
  3. Opie LH, Walpoth B, Barsacchi R. Calcium and catecholamines: relevance to cardiomyopathies and significance in therapeutic strategies.J Mol Cell Cardiol 1985; 17(Suppl 2):21–34.
  4. Costa VM, Carvalho F, Bastos ML, Carvalho RA, Carvalho M, Remião F. Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases. Curr Med Chem 2011;18(15):2272–314.
  5. Rosenbaum JS, Billingham ME, Ginsburg R, Tsujimoto G, Lurie KG, Hoffman BB. Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations. Am J Cardiovasc Pathol 1988;1(3):389–99.
  6. Tschöpe C, Van Linthout S, Klein O, Mairinger T, Krackhardt F, Potapov EV, Schmidt G, Burkhoff D, Pieske B, Spillmann F. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA,and PROPELLA Concepts. J Cardiovasc Transl Res 2019; 12:116–123.
  7. Hekimian G, Kharcha F, Bréchot N, Schmidt M, Ghander C, Lebreton G, Girerd X, Tresallet C, Trouillet JL, Leprince P, Chastre J, Combes A and Luyt CE. Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann. Intensive Care2016; 6:117.
  8. Riester A, Weismann D, Quinkler M, Lichtenauer UD, Sommerey S, Halbritter R, Penning R, Spitzweg C, Schopohl J, Beuschlein F, Reincke M. Life‐threatening events in patients with pheochromocytoma.Eur J Endocrinol 2015; 173(6):757–64.